Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Explore which risk parity funds are retirement friendly and fit conservative to balanced retirement goals. A quick guide to evaluating suitability.
27,924 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
SpaceX IPO buzz is electric. Here are the two simplest routes retail investors can use to access shares at the IPO pr...
For years, SK Hynix has traded at a discount to Micron. This article explains why the gap exists, what could close it...
Investors are watching whispers about Apple and Intel teaming up. This article breaks down what that could mean for s...
A federal case in Arizona highlights how pandemic-era tax credits can be abused. Learn how these schemes operated, wh...
Two crypto treasury desks, Sharplink and Forward, are joining Russell’s U.S. index family, signaling growing mainstre...
Rising capex threatens the cash-flow yields that power popular cash cows. This report explains why and what investors...
Ripple reveals an AI-driven security upgrade for the XRP Ledger after a batch-transaction bug. The move aims to harde...
Ethereum surged to a six-week high as institutional buying and treasury activity boosted ETH. This article breaks dow...
Across Latin America, a new wave of fintechs is defying expectations. This article dives into three standout players,...
Quantum computing stocks ionq, Rigetti, and D-Wave have captured investor imaginations with big promises and big vola...
The Bank of England's top regulator raises alarms about dollar-pegged tokens and oversight gaps, foreshadowing a tens...